Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:35 PM ET Form 4
Insider Selling Jack in the Box Inc JACK

Jack in the Box Exec Chairman & Interim CEO Mark James King Sells $113K of Stock

Mark James King, Exec Chairman & Interim CEO, sold 7,977 shares of Jack in the Box Inc at $14.11 a share, worth $113K in total on Nov 13, 2026. Shares held after the trade: 161,288 (-4.7%).

Value
$113K
Shares
7,977
Price
$14.11
Role
Exec Chairman & Interim CEO
Holding change
-4.7%
Trade date
Nov 13, 2026
5:34 PM ET Form 4
Insider Selling Veradermics, Inc MANE

Veradermics 10% Owner Longitude Capital Partners V LLC Sells $75.2M of Stock

Longitude Capital Partners V LLC, 10% Owner, sold 500,000 shares of Veradermics, Inc at $150.38 a share, worth $75.2M in total on Nov 11, 2026. Shares held after the trade: 1,803,474 (-12.2%).

Value
$75.2M
Shares
500,000
Average price
$150.38
Role
10% Owner
Holding change
-12.2%
Trade date
Nov 11, 2026
5:34 PM ET Form 4
Insider Buying Neonc Technologies Holdings, Inc. NTHI

Neonc Technologies Holdings CEO, President Amir F. Heshmatpour Buys $151K of Stock

Amir F. Heshmatpour, CEO, President, bought 30,000 shares of Neonc Technologies Holdings, Inc. at $5.02 a share, worth $151K in total on Nov 13, 2026. Shares held after the trade: 3,353,000 (+0.9%).

Value
$151K
Shares
30,000
Price
$5.02
Role
CEO, President
Holding change
+0.9%
Trade date
Nov 13, 2026
5:34 PM ET Form 4
Insider Selling Sinclair, Inc. SBGI

Sinclair COO & President of Local Media Robert Weisbord Sells $150K of Stock

Robert Weisbord, COO & President of Local Media, sold 10,000 shares of Sinclair, Inc. at $15.02 a share, worth $150K in total on Nov 11, 2026. Shares held after the trade: 289,408 (-3.3%).

Value
$150K
Shares
10,000
Price
$15.02
Role
COO & President of Local Media
Holding change
-3.3%
Trade date
Nov 11, 2026
5:33 PM ET Form 4
Insider Buying Global Partners LP GLP

Global Partners Insider Global GP LLC Buys $442K of Stock

Global GP LLC bought 10,000 shares of Global Partners LP at $43.79 to $44.56 a share (average $44.25) in 3 transactions, worth $442K in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 181,584 (+1.4%).

Value
$442K
Shares
10,000
Average price
$44.25
Holding change
+1.4%
Trade date
Nov 11, 2026 to Nov 13, 2026
5:31 PM ET 10-Q
Financial Results Alset Inc. AEI

Alset Q3 2026 Results: Net Income $5.17M, Up 242.0% YoY

Alset Inc. reported a net loss of $6.7 million for the nine months ended September 30, 2026, compared to a $16.4 million loss in the prior year period. Total revenue decreased slightly to $2.9 million, while the company recognized a significant $6.1 million gain from the deconsolidation of ESYN during the third quarter.

Key figure
Net income $5.17M · +242.0% YoY
5:30 PM ET 10-Q
Financial Results Perpetua Resources Corp. PPTA

Perpetua Resources Q3 2026 Results: Net Loss of $79.2M, Loss Widens

Perpetua Resources Corp. reported a significant increase in net loss to $225.3 million for the nine months ended September 30, 2026, primarily driven by a surge in exploration and pre-development expenses. The company's cash position decreased to $443.4 million as it continues to invest in the Stibnite Gold Project and awaits full project financing.

Key figure
Net loss $79.2M
5:29 PM ET Form 4
Insider Selling Bristow Group Inc. VTOL

Bristow Group Insider Solus Alternative Asset Management LP Sells $2.98M of Stock

Solus Alternative Asset Management LP sold 73,600 shares of Bristow Group Inc. at $40.37 to $41.45 a share (average $40.44) in 4 transactions, worth $2.98M in total between Nov 10, 2026 and Nov 13, 2026. Shares held after the trade: 2,766,836 (-0.2%).

Value
$2.98M
Shares
73,600
Average price
$40.44
Holding change
-0.2%
Trade date
Nov 10, 2026 to Nov 13, 2026
5:29 PM ET 10-Q
Financial Results TPG Twin Brook Capital Income Fund

TPG Twin Brook Capital Income Fund Q3 2026 Results: Net Income $66.1M, Up 64.2% YoY

TPG Twin Brook Capital Income Fund reported total investment income of $359.4 million for the nine months ended September 30, 2026, up from $288.6 million in the prior year period. Net assets grew to $2.79 billion as of September 30, 2026, driven by $405.4 million in net capital share transactions and $187.9 million in net increase in net assets from operations.

Key figure
Net income $66.1M · +64.2% YoY
5:29 PM ET 10-Q
Financial Results Dragonfly Energy Holdings Corp. DFLI

Dragonfly Energy Holdings Q3 2026 Results: Net Loss of $5.54M, Loss Narrows

Dragonfly Energy reported a net loss of $16.6 million for the nine months ended September 30, 2026, compared to a $24.9 million loss in the prior year period. Net sales decreased to $35.0 million from $45.6 million year-over-year, while the company's cash position significantly declined to $1.9 million as of September 30, 2026.

Key figure
Net loss $5.54M
5:29 PM ET 10-Q
Financial Results Syntec Optics Holdings, Inc. OPTX

Syntec Optics Holdings Q3 2026 Results: Turns Profitable, Net Income $247K

Syntec Optics reported net sales of $23.3 million for the nine months ended September 30, 2026, a 13.4% increase over the prior year. Despite the revenue growth, the company recorded a net loss of $395,046 for the period, though this was a significant improvement from the $1.45 million loss in 2025. The company's cash position strengthened substantially to $14.4 million following $23 million in gross proceeds from a common stock issuance.

Key figure
Net income $247K
5:29 PM ET 8-K
Investor Presentation Macrogenics Inc MGNX

Macrogenics Investor Presentation

MacroGenics, Inc. made available an updated corporate presentation on its website and as an exhibit to its 8-K filing. The presentation provides updated clinical program details and strategic priorities for the company's therapeutic candidates. The filing serves as a Regulation FD disclosure to ensure the updated information is available to the public and investors.

5:28 PM ET 10-Q
Financial Results Canary XRP ETF XRPC

Canary XRP ETF Q3 2026 Results: Net Income $104M

As of September 30, 2026, the Canary XRP ETF held $368.8 million in XRP, representing a net asset value of $15.79 per share. For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $60.5 million, primarily driven by $50.2 million in unrealized depreciation and $9.2 million in realized losses on its crypto currency investments.

Key figure
Net income $104M
5:28 PM ET 10-Q
Financial Results Eightco Holdings Inc. ORBS

Eightco Holdings Q3 2026 Results: Turns Profitable, Net Income $54.4M

Eightco Holdings Inc. reported a significant shift in its business model towards a Digital Asset Treasury Strategy, with total assets increasing to $446.3 million as of September 30, 2026, primarily driven by $205.4 million in digital assets and $82.6 million in stablecoins. However, the company experienced a sharp decline in revenues to $9.7 million for the nine months ended September 30, 2026, compared to $22.8 million in the prior year, resulting in an operating loss of $25.9 million.

Key figure
Net income $54.4M
5:28 PM ET 10-Q
Financial Results Apollo Asset Backed Credit Co LLC

Apollo Asset Backed Credit Co Q3 2026 Results: Net Income $18M, Down 16.3% YoY

Apollo Asset Backed Credit Company LLC reported total net assets of approximately $1.98 billion as of September 30, 2026, across its Series I and Series II interests. The company, an emerging growth company, saw its total assets grow to $2.52 billion from $1.89 billion at the end of 2025, driven primarily by an increase in investments at fair value.

Key figure
Net income $18M · -16.3% YoY
5:28 PM ET 8-K
Financial Results Tempest Therapeutics, Inc. TPST

Tempest Therapeutics Financial Results

Tempest Therapeutics reported third quarter 2026 financial results and provided a business update on its in vivo CAR-T pipeline, including the lead candidate TPST-4903. During the quarter, the company exercised its option for an exclusive license to Senlang's CD7-targeted platform and secured access to capital through a $50 million equity line of credit and a $2.5 million private placement.

“The third quarter marked a period of meaningful progress in the advancement of two next-generation in vivo CAR-T platforms with the potential to transform treatment across multiple diseases.”

Matt Angel, Ph.D., president and chief executive officer of Tempest

“We made important strides in expanding our pipeline and strengthening our position in the rapidly evolving in vivo CAR-T landscape through our strategic collaboration with Senlang by obtaining exclusive license rights to our clinical-stage BCMA/GPRC5D in vivo CAR-T candidate TPST-4903, while securing access to additional capital to support our development priorities.”

Matt Angel, Ph.D., president and chief executive officer of Tempest
5:28 PM ET 8-K
Financial Results BeyondSpring Inc. BYSI

BeyondSpring Financial Results

BeyondSpring reported Q3 2026 financial results and highlighted that the FDA granted Fast Track designation for Plinabulin in combination with docetaxel for certain NSCLC patients. The company also completed a strategic transaction with Biolin to fund approximately half of the enrollment for the Phase 3 DUBLIN-4 trial.

Term
Q3 2026

“The FDA’s Fast Track designation underscores the significant unmet need for new treatment options for NSCLC patients without AGA and progressing after immune checkpoint inhibitor therapy, where docetaxel is still the standard of care.”

Min Qiu, Chief Executive Officer of BeyondSpring

“With an FDA-aligned Phase 3 design and a strategic transaction with Biolin to support approximately half of DUBLIN-4’s planned 442-patient enrollment, generating quality data from China, we remain focused on advancing the study toward its prespecified interim analysis at 221 progression-free survival events.”

Min Qiu, Chief Executive Officer of BeyondSpring
5:27 PM ET 10-Q
Financial Results Awaysis Capital, Inc. AWCA

Awaysis Capital Q1 2026 Results: Net Loss of $603K, Loss Narrows

Awaysis Capital, Inc. reported a net loss of $602,539 for the three months ended September 30, 2026, compared to a net loss of $651,548 in the prior year period. Revenue increased to $164,671 from $95,198, while the company continued to focus on its vacation rental and real estate development activities in Belize.

Key figure
Net loss $603K
5:27 PM ET 8-K
Financial Results BCP Investment Corp BCIC

BCP Investment Financial Results

BCP Investment Corporation reported Q3 2026 financial results with total investment income of $13.9 million and net investment income of $4.6 million ($0.37 per share). The company also announced a definitive merger agreement to acquire Investcorp Credit Management BDC, Inc. (ICMB) at 90% of its closing NAV. Additionally, BCIC declared monthly base distributions of $0.09 per share for the first quarter of 2027.

Term
Q3 2026
5:26 PM ET 10-Q
Financial Results Forum Markets Inc FRMM

Forum Markets Q3 2026 Results: Turns Profitable, Net Income $7.85M

FORUM MARKETS Inc. reported a net income of $7.85 million for the quarter ended September 30, 2026, a significant recovery from a $216.7 million loss in the prior year. The company transitioned its revenue model toward aircraft engine rentals while managing a substantial accumulated deficit of $673.3 million.

Key figure
Net income $7.85M
5:26 PM ET 8-K
M&A Deal Mistras Group, Inc. MG

Mistras Group M&A Deal with Athena Purchaser, LLC

Mistras Group provided a status update on its pending acquisition by Athena Purchaser, LLC (an affiliate of H.I.G. Capital), disclosing that two lawsuits and multiple demand letters have been filed by stockholders alleging deficient disclosures in the merger proxy statement. The company maintains that the claims are without merit but is filing supplemental disclosures ahead of the special stockholder meeting scheduled for November 24, 2026.

Counterparty
Athena Purchaser, LLC
5:26 PM ET 10-Q
Financial Results Tempest Therapeutics, Inc. TPST

Tempest Therapeutics Q3 2026 Results: Net Loss of $3.63M, Loss Widens

Tempest Therapeutics filed its Q3 2026 10-Q reporting 19,995,358 shares of common stock outstanding as of November 13, 2026. The company is focused on advancing its clinical-stage programs, including TPST-4003 and TPST-2003, while addressing substantial risks regarding its ability to continue as a going concern and maintain Nasdaq listing compliance.

Key figure
Net loss $3.63M
5:26 PM ET 8-K
Capital Raise CareTrust REIT, Inc. CTRE

CareTrust REIT Capital Raise of $704M

CareTrust REIT entered into forward sale agreements for 19,550,000 shares of common stock at an initial forward price of $36.00 per share. The transaction includes an initial 17,000,000 shares and the full exercise of an underwriters' option for an additional 2,550,000 shares. The company intends to physically settle the agreements for cash proceeds by November 12, 2027, to fund future acquisitions and for general corporate purposes.

Value
$704M
Counterparty
BofA Securities, Inc. and Morgan Stanley & Co. LLC
Term
through Nov 2027
5:25 PM ET 10-Q
Financial Results RTB Digital, Inc. RTB

RTB Digital Q3 2026 Results: Net Loss of $5.08M, Loss Widens

RTB Digital, Inc. reported a significant revenue increase to $6.29 million for the nine months ended September 30, 2026, compared to $1.44 million in the prior year, driven by expansion and acquisitions. However, the company incurred a net loss of $19.44 million during this period, primarily due to a sharp rise in general and administrative expenses and losses on the sale of crypto assets.

Key figure
Net loss $5.08M
5:25 PM ET 8-K
Other 8-K Filing Mangoceuticals, Inc. MGRX

Mangoceuticals Other 8-K Filing

Mangoceuticals amended its Series B and Series C preferred stock designations and established a new Series D Preferred Stock class. The Series D Preferred Stock will rank senior to common stock and existing preferred classes regarding dividends and liquidation, though no shares were issued at the time of filing. The amendments include waivers from existing preferred holders to allow for the senior ranking and future Series D transactions.

5:25 PM ET 10-Q
Financial Results Ciso Global, Inc. CISO

Ciso Global Q3 2026 Results: Net Loss of $3.14M

CISO Global reported total revenue of $17.6 million for the nine months ended September 30, 2026, a decrease from $20.3 million in the prior year period. The company reported a net loss of $6.3 million for the first nine months of 2026 and expressed substantial doubt about its ability to continue as a going concern.

Key figure
Net loss $3.14M
5:25 PM ET 10-Q
Financial Results GBank Financial Holdings Inc. GBFH

GBank Financial Holdings Q3 2026 Results: Net Income $3.85M, Down 10.6% YoY

GBank Financial Holdings Inc. reported on its financial condition for the quarter ended September 30, 2026, highlighting risks related to credit quality, inflationary pressures, and cybersecurity. As of November 13, 2026, the company had 14,571,526 shares of common stock outstanding and is classified as an emerging growth company.

Key figure
Net income $3.85M · -10.6% YoY
5:25 PM ET 10-Q
Financial Results Canary Hbar ETF HBR

Canary Hbar ETF Q3 2026 Results: Net Income $29.4M

Canary HBAR ETF reported net assets of $87.5 million as of September 30, 2026, a significant increase from $50.6 million at the end of 2025, driven by $30.4 million in net capital share transactions and $6.5 million in net increase from operations. The Trust's investment in Hedera (HBAR) grew to over 806 million units, though it recorded a net investment loss of $383,993 for the nine-month period due to sponsor fees.

Key figure
Net income $29.4M
5:25 PM ET 10-Q
Financial Results Silvia, Inc. SVIA

Silvia Q3 2026 Results: Net Income $123M, Up 22.3% YoY

Silvia, Inc. reported a net loss of $49.95 million for the nine months ended September 30, 2026, primarily driven by $17.65 million in unrealized losses on digital assets and $11.01 million in stock-based compensation. Despite the year-to-date loss, the company achieved a net income of $122.85 million in the third quarter of 2026 due to a significant $137.18 million unrealized gain on digital assets.

Key figure
Net income $123M · +22.3% YoY
5:25 PM ET 10-Q
Financial Results Talon Capital Corp. TLNC

Talon Capital Q3 2026 Results: Net Income $1.99M, Up 417.2% YoY

Talon Capital Corp. reported net income of $5,279,431 for the nine months ended September 30, 2026, primarily driven by $7,057,830 in interest earned on cash held in the Trust Account. The company remains a shell company with $258,717,921 in Class A ordinary shares subject to possible redemption and a total shareholders' deficit of $8,576,577.

Key figure
Net income $1.99M · +417.2% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.